FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: THE RULES OF PROCEDURE FOR THE SUPERVISORY COMMITTEE
FUDANZHANGJIANG: THE RULES OF PROCEDURE FOR THE BOARD OF DIRECTORS
FUDANZHANGJIANG: THE RULES OF PROCEDURE FOR THE GENERAL MEETING
FUDANZHANGJIANG: ARTICLES OF ASSOCIATION
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: Final Dividend for the Year Ended 31 December 2023
FUDANZHANGJIANG: INSIDE INFORMATION-TERMINATION OF PROMOTION SERVICE AGREEMENT WITH SHANGHAI HUIZHENG
FUDANZHANGJIANG: INDICATIVE ANNOUNCEMENT-FIRST PATIENT ENROLLED IN CONFIRMATORY CLINICAL TRIAL OF AMINOLEVULINIC ACID HYDROCHLORIDE POWDER FOR ORAL SOLUTION FOR INTRAOPERATIVE VISUALISATION OF GLIOMA
FUDANZHANGJIANG: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
FUDANZHANGJIANG: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
FUDANZHANGJIANG: Overseas Regulatory Announcement-Haitong Securities Co., Ltd.'s Review of Information Disclosure Regulatory Inquiry Letter on Shanghai Fudan Zhangjiang Biopharmaceutical Co., Ltd. 2023 Annual Report
FUDANZHANGJIANG: Overseas Regulatory Announcement - Pwai Wing Road's specific response to the questions raised by Fudan Zhang Jiang in the inquiry letter to the 2023 Annual Report
FUDANZHANGJIANG: Overseas Regulatory Announcement - Response Notice to Regulatory Inquiry Regarding Information Disclosure of 2023 Annual Report
FUDANZHANGJIANG: Overseas Regulatory Announcement-HAITUNG SECURITIES CO., LTD. ON SHANGHAI FUDAN ZHANGJIANG BIOMEDICAL CO., LTD. USED TEMPORARILY IDLE FUNDRAISING FOR CASH MANAGEMENT
FUDANZHANGJIANG: Overseas Regulatory Announcement - Notice Concerning Cash Management Using Temporarily Idle Raising Funds
FUDANZHANGJIANG: Overseas Regulatory Announcement - Notice of Resolution of the Fifth Meeting of the 8th Board of Supervisors
No Data